Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 23, 2014

View Archived Issues

Minimizing TBI in mice by pharmacological induction of hypothermia

Direct inhibition of InhA to combat drug-resistant TB

Preclinical and phase I results presented for LY-2452473

GeNeuro presents novel clinical and preclinical results for GNbAC-1

Spring Bank Pharmaceuticals collaborates with NIH to test SB-9200

Adenium Biotech presents a novel antibacterial peptide for Gram-negative bacteria

AGI-12026, a novel potent and selective IDH2 R140Q inhibitor shows promise in vivo

Kancera updates on drugs and vaccines targeting ROR1

Alios BioPharma updates on preclinical NS5B inhibitors for HCV infection

biOasis Technologies supports new preclinical study of Transcend technology in MPS II

Telavic receives additional indication approval in Japan

Novel ROCK1 and ROCK2 inhibitors disclosed by Bristol-Myers Squibb

Purdue Pharma divulges novel Na(V)1.7 blockers for pain

Novel BRD4 inhibitors synthesized by Bristol-Myers Squibb

Transparency Life Sciences to conduct trial of Kiacta in sarcoidosis

Amgen submits BLA for BiTE immunotherapy blinatumomab

Avalon Ventures and GlaxoSmithKline launch two new companies

Researchers at Washington University disclose novel GABA(A) receptor modulators

Soligenix awarded NIAID contract to develop heat stable RiVax vaccine

Once-weekly GH replacement therapy with MOD-4023 shows promise in pediatric patients

Immunosuppressive agent Thymoglobuline approved for additional indication in Japan

Vidara Therapeutics acquired by Horizon Pharma

Kerydin launched in U.S. for onychomycosis

Noxxon's spiegelmer awarded U.S. orphan drug designation for glioblastoma

FDA and Health Canada permit expanded access administration of Tekmira's TKM-Ebola

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...